Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
An automated, CE-marked diagnostic test for 17-Hydroxyprogesterone (17-OH P) is among the assays that are being demonstrated by Immunodiagnostic Systems Holdings PLC (Tyne & Wear, United Kingdom) in Booth 137 at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

17-Hydroxyprogesterone (17-OH P) is a steroid hormone produced in both the adrenal gland and gonads, which is synthesized from either progesterone or 17-hydroxypregnenolone. More...
It functions as a precursor of cortisol in the adrenal glands or is converted into androgenic and estrogenic hormones. Measurement of 17-OH P is used as an aid in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries.

The IDS-iSYS 17-OH Progesterone assay is an in vitro diagnostic device intended for use with the IDS-iSYS Multi-Discipline Automated System for the quantitative determination of 17-OH Progesterone in human serum or plasma.

The iSYS Multi-Discipline Automated System presents a total instrument solution based on simplicity and reliability with full walk-away automation in a compact, bench-top design. The instrument features on-board refrigeration of ready-to-use reagent cartridges, continuous loading with batch, random, and STAT flexibility with easy operation from auto start-up to shutdown.

Related Links:
Immunodiagnostic Systems
AACC Annual Meeting & Clinical Lab Expo

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.